Protective effect of Lonicerae japonicae flos extract against doxorubicin-induced liver injury in mice

doi:10.12122/j.issn.1673-4254.2024.08.16

Abstract

Abstract:

Objective To explore the mechanism underlying the protective effect of Lonicerae japonicae flos (LJF) extract against doxorubicin (DOX)-induced liver injury in mice. Methods Network pharmacology methods were used to obtain the intersection genes between LJF targets and disease targets, based on which the protein-protein interaction (PPI) network was constructed using STRING database for screening the core targets using Cytoscape software. DAVID database was used for bioinformatics analysis, and the core components and core targets were verified using molecular docking study. In a mouse model of DOX-induced liver injury, the effect of LJF extract on liver pathologies, serum levels of ALT and AST, and hepatic expressions of HYP, ROS, TNF-α, IL-6, COL-IV and P53 proteins were evaluated using HE and Masson staining, ELISA, and Western blotting. Results We identified 12 core targets from 43 intersection genes involving cancer pathway, IL-17 signaling pathway, and TNF signaling pathways. Molecular docking study suggested that 10 core components of LJF could bind to different core targets. The mice with DOX-induced liver injury showed elevated serum AST and ALT levels with obvious liver injury and fibrosis, increased ROS content, and enhanced expressions of TNF-α, IL-6, HYP, COL-IV and P53 proteins in the liver tissue. All these changes in the mouse models were significantly alleviated by treatment with LJF extract, suggesting obviously lowered levels of oxidative stress, inflammation and fibrosis in the liver tissues. Conclusion LJF extract is capable of alleviating DOX-induced liver injury in mice by downregulating Trp53, TNF and IL-6 to reduce liver oxidative stress, inflammation and fibrosis.

Key words: network pharmacology, Lonicerae japonicae flos, doxorubicin, liver damage, oxidative stress, liver fibrosis, inflammation

Yuming ZHANG, Shicheng XIA, Linlin ZHANG, Mengxi CHEN, Xiaojing LIU, Qin GAO, Hongwei YE. Protective effect of Lonicerae japonicae flos extract against doxorubicin-induced liver injury in mice[J]. Journal of Southern Medical University, 2024, 44(8): 1571-1581.

Figures/Tables 12

Fig.1 Venn diagram of Lonicerae japonicae flos, Adriamycin-induced liver injury and hepatic fibrosis-related targets.

Fig.2 PPI network diagram (A) and core targets network diagram (B).

Fig.3 GO (A) and KEGG (B) enrichment analysis.

Tab.1 Core components of Lonicerae japonicae flos

Mol ID	Molecule	OB	DL
MOL000006	luteolin	36.16	0.25
MOL000098	quercetin	46.43	0.28
MOL000422	kaempferol	41.88	0.24
MOL002914	Eriodyctiol (flavanone)	41.35	0.24
MOL003006	(-)-(3R,8S,9R,9aS,10aS)-9-ethenyl-8-(beta-D-glucopyranosyloxy)-2,3,9,9a,10,10a-hexahydro-5-oxo-5H,8H-pyrano[4,3-d]oxazolo[3,2-a]pyridine-3-carboxylic acid_qt	87.47	0.23
MOL003014	secologanic dibutylacetal_qt	53.65	0.29
MOL003044	Chryseriol	35.85	0.27
MOL003095	5-hydroxy-7-methoxy-2-(3,4,5-trimethoxyphenyl)chromone	51.96	0.41
MOL003111	Centauroside_qt	55.79	0.5
MOL003117	Ioniceracetalides B_qt	61.19	0.19

Tab.2 Binding energy of the core targets and core ingredients (kcal/mol)

Mol ID	TrP53 Binding energy	TNF Binding energy	IL-6 Binding energy
MOL000006	-4.49	-5.8	-3.93
MOL000098	-3.93	-5.6	-4.24
MOL000422	-4.85	-5.62	-4.59
MOL002914	-5.61	-5.09	-4.75
MOL003006	-4.7	-6.97	-5.31
MOL003014	-2.53	-2.96	-0.83
MOL003044	-5.02	-5.99	-5.1
MOL003095	-4.7	-4.9	-3.59
MOL003111	-2.85	-4.11	-3.23
MOL003117	-4.94	-4.79	-4.24

Fig.4 Visualization of molecular docking results. A: Potential interaction between MOL002914 and Trp53. B: Potential interaction between MOL003044 and Trp53. C: Potential interaction between MOL003044 and TNF. D: Potential interaction between MOL003006 and TNF. E: Potential interaction between MOL003006 and IL-6. F: Potential interaction between MOL003044 and IL-6.

Fig.5 Serum levels of AST (A) and ALT (B) in mice in each group (Mean±SD, n=6). ***P<0.001 vs Sham; ###P<0.001 vs DOX; $P<0.05, $$P<0.01 vs DOX+LJF (0.2 g/kg); &&P<0.01 vs DOX+LJF (0.4 g/kg).

Fig.6 HE staining of mouse liver tissues in each group (Original magnification: ×40). Black arrows indicate erythrocyte exudates, red arrows indicate hepatocyte ballooning, and blue arrows indicate inflammatory cell infiltration.

Fig.7 Masson staining of mouse liver tissue in each group (×120). The black arrows indicate fibrotic hyperplasia and the red arrows indicate hepatocyte balloons.

Fig.9 TNF-α (A) and IL-6 (B) levels in mouse liver tissues in each group (Mean±SD, n=6). ***P<0.001 vs Sham; ###P<0.001 vs DOX; $$P<0.01, $$$P<0.001 vs DOX+LJF (0.2 g/kg) ; &&P<0.01 vs DOX+LJF (0.4 g/kg).

Fig.10 HYP (A) and COL-IV (B) levels in mouse liver tissues in each group (Mean±SD, n=6). ***P<0.001 vs Sham; ###P<0.001 vs DOX; $P<0.05, $$P<0.01, $$$P<0.001 vs DOX+LJF (0.2 g/kg) ; &P<0.05, &&P<0.01 vs DOX+LJF (0.4 g/kg).

Fig.11 Protein expression level of P53 in mouse liver tissue in each group (Mean±SD, n=6). A: P53 protein expression detected by Western blotting in each group. B: Quantitative data of P53 expression. ***P<0.001 vs Sham; ###P<0.001, ##P<0.01, #P<0.05 vs DOX; &P<0.05 vs DOX+LJF (0.2 g/kg).

References 34

1	Powers SK, Duarte JA, Le Nguyen B, et al. Endurance exercise protects skeletal muscle against both doxorubicin-induced and inactivity-induced muscle wasting[J]. Pflugers Arch, 2019, 471(3): 441-53.
2	Li DK, Zhang W, Fu H, et al. DL-3-n-butylphthalide attenuates doxorubicin-induced acute cardiotoxicity via Nrf2/HO-1 signaling pathway[J]. Heliyon, 2024, 10(5): e27644.
3	Chen MY, Yi YD, Chen BX, et al. Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice[J]. Toxicology, 2024, 503: 153757.
4	Badi RM, Khaleel EF, Satti HH, et al. Eriodictyol attenuates doxorubicin-induced nephropathy by activating the AMPK/Nrf2 signalling pathway[J]. J Tradit Complementary Med, 2024, 14(2): 203-14.
5	Liu PP, Wu J, Yu XY, et al. Metabolomics and network analyses reveal phenylalanine and tyrosine as signatures of anthracycline-induced hepatotoxicity[J]. Pharmaceuticals, 2023, 16(6): 797.
6	Wali AF, Rashid S, Rashid SM, et al. Naringenin regulates doxorubicin-induced liver dysfunction: impact on oxidative stress and inflammation[J]. Plants, 2020, 9(4): 550.
7	AlAsmari AF, Alharbi M, Alqahtani F, et al. Diosmin alleviates doxorubicin-induced liver injury via modulation of oxidative stress-mediated hepatic inflammation and apoptosis via NfkB and MAPK pathway: a preclinical study[J]. Antioxidants, 2021, 10(12): 1998-2013.
8	Shati AA, Eid RA, El-Kott AF, et al. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative Stress, preventing inflammation and apoptosis: Ultrastructural and computational approaches[J]. Heliyon, 2024, 10(5): e27164-75.
9	Morsy MA, El-Daly M, Kamel BA, et al. Pregnenolone protects the liver against doxorubicin-induced cellular injury by anti-inflammatory, antioxidant, and antiapoptotic mechanisms: role of Keap1/Nrf2/HO-1 and P-glycoprotein[J]. Eur Rev Med Pharmacol Sci, 2023, 27(10): 4718-34.
10	Metwally AA, Ganguly S, Biomi N, et al. Cationic vitamin E-TPGS mixed micelles of berberine to neutralize doxorubicin-induced cardiotoxicity via amelioration of mitochondrial dysfunction and impeding apoptosis[J]. Molecules, 2024, 29(5): 1155.
11	李康宁, 宋志领, 贾利龙, 等. 金银花提取物对LPS诱导的急性前部葡萄膜炎小鼠的抗炎作用及其机制[J]. 吉林大学学报: 医学版, 2021, 47(4): 978-83.
12	周慧敏, 马秀梅, 曾海生, 等. 金银花醇提物抗炎、降血脂作用实验研究[J]. 中医药导报, 2022, 28(7): 5–10.
13	汤菲菲, 马兰. 不同剂量金银花口服液对风热症患儿症状积分改善及预后的影响[J]. 中国医学创新, 2022, 19(26): 77-80.
14	单贺珍, 董石, 李晓瑞, 等. 金银花提取物增强抗CD19 CAR-T细胞肿瘤杀伤活性[J]. 中南药学, 2022, 20(7): 1545-9.
15	Lin YL, Wu YH S, Chao MY, et al. An alleviative effect of Lonicerae japonicae flos water extract against liver fibrogenesis in vitro and in vivo [J]. Environ Toxicol, 2024, 39(5): 2881-92.
16	Zhang YN, Zhu GH, Liu W, et al. Discovery of the covalent SARS-CoV-2 M^pro inhibitors from antiviral herbs via integrating target-based high-throughput screening and chemoproteomic approaches[J]. J Med Virol, 2023, 95(11): e29208.
17	Miao H, Zhang Y, Huang ZL, et al. Lonicera japonica attenuates carbon tetrachloride-induced liver fibrosis in mice: molecular mechanisms of action[J]. Am J Chin Med, 2019, 47(2): 351-67.
18	Tao RH, Kobayashi M, Yang YZ, et al. Exercise inhibits doxorubicin-induced damage to cardiac vessels and activation of hippo/YAP-mediated apoptosis[J]. Cancers, 2021, 13(11): 2740.
19	Santos-Alves E, Rizo-Roca D, Marques-Aleixo I, et al. Physical exercise positively modulates DOX-induced hepatic oxidative stress, mitochondrial dysfunction and quality control signaling[J]. Mitochondrion, 2019, 47: 103-13.
20	Bilgic S, Ozgocmen M. The protective effect of misoprostol against doxorubicin induced liver injury[J]. Biotech Histochem, 2019, 94(8): 583-91.
21	Zhou XN, Lu QQ, Kang XZ, et al. Protective role of a new polysaccharide extracted from Lonicera japonica thunb in mice with ulcerative colitis induced by dextran sulphate sodium[J]. Biomed Res Int, 2021, 2021: 8878633.
22	Zhang JM, Li WL, Xue SM, et al. Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3[J]. J Ethnopharmacol, 2024, 319(Pt 1): 117134.
23	郝梦超, 姚甜, 刘二奴, 等. 忍冬中的活性成分及其药理活性研究现状[J]. 药物分析杂志, 2024, 44(2): 195–213.
24	张倩, 张梅奎, 刘颖璐, 等. 六味酸枣汤治疗围绝经期失眠的作用机制: 基于网络药理学与动物实验[J]. 南方医科大学学报, 2023, 43(9): 1536-47.
25	陈君洁, 黄传兵, 李明. 健脾滋肾方抑制系统性红斑狼疮患者的足细胞自噬: 基于网络药理学和临床研究[J]. 南方医科大学学报, 2024, 44(3): 465-73.
26	Song L, Chen TY, Zhao XJ, et al. Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF‑β1/Smads signalling[J]. Br J Pharmacol, 2019, 176(11): 1619-34.
27	李亚龙. CNPY2介导p53/p66Shc通路在有氧运动干预非酒精性脂肪肝中的作用研究[D]. 成都: 成都体育学院, 2022.
28	Zhao J, Han M, Zhou L, et al. TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF‑κB/NLRP3 inflammasome signaling pathways[J]. Hepatol Int, 2020, 14(1): 145-60.
29	王咏兰, 陶柏楠, 陈明环, 等. 基于JAK2/STAT3信号通路探究鬼箭羽醇提物抗CCl₄诱导C57BL/6J小鼠肝纤维化作用机制[J]. 中国药理学通报, 2023, 39(5): 875-81.
30	Song SS, Chu L, Liang HF, et al. Protective effects of dioscin against doxorubicin-induced hepatotoxicity Via regulation of Sirt1/FOXO1/NF-κb signal[J]. Front Pharmacol, 2019, 10: 1030-9.
31	Wan HQ, Ge LL, Li JM, et al. Effects of a novel biflavonoid of Lonicera japonica flower buds on modulating apoptosis under different oxidative conditions in hepatoma cells[J]. Phytomedicine, 2019, 57: 282-91.
32	Cenacchi V, Furlanis G, Menichelli A, et al. Co-ultraPEALut in subjective cognitive impairment following SARS-CoV-2 infection: an exploratory retrospective study[J]. Brain Sci, 2024, 14(3): 293.
33	Lou JT, Wu F, He WH, et al. Hesperidin activates Nrf2 to protect cochlear hair cells from cisplatin-induced damage[J]. Redox Rep, 2024, 29(1): 2341470-9.
34	Aon-Im P, Monthakantirat O, Daodee S, et al. Evaluation of the impact of Alternanthera philoxeroides (mart.) Griseb. extract on memory impairment in D-galactose-induced brain aging in mice through its effects on antioxidant enzymes, neuroinflammation, and telomere shortening[J]. Molecules, 2024, 29(2): 503-16.

[1]	Xinyuan CHEN, Chengting WU, Ruidi LI, Xueqin PAN, Yaodan ZHANG, Junyu TAO, Caizhi LIN. Shuangshu Decoction inhibits growth of gastric cancer cell xenografts by promoting cell ferroptosis via the P53/SLC7A11/GPX4 axis [J]. Journal of Southern Medical University, 2025, 45(7): 1363-1371.
[2]	Zhengyuan FAN, Zihan SHEN, Ya LI, Tingting SHEN, Gaofeng LI, Suyun LI. Protective effect of Bufei Yishen Formula against cigarette smoke extract-induced human bronchial epithelial cell damage and its mechanism [J]. Journal of Southern Medical University, 2025, 45(7): 1372-1379.
[3]	Liming WANG, Hongrui CHEN, Yan DU, Peng ZHAO, Yujie WANG, Yange TIAN, Xinguang LIU, Jiansheng LI. Yiqi Zishen Formula ameliorates inflammation in mice with chronic obstructive pulmonary disease by inhibiting the PI3K/Akt/NF-κB signaling pathway [J]. Journal of Southern Medical University, 2025, 45(7): 1409-1422.
[4]	Yinfu ZHU, Yiran LI, Yi WANG, Yinger HUANG, Kunxiang GONG, Wenbo HAO, Lingling SUN. Therapeutic mechanism of hederagenin, an active component in Guizhi Fuling Pellets, against cervical cancer in nude mice [J]. Journal of Southern Medical University, 2025, 45(7): 1423-1433.
[5]	Jingxian WANG, Zijing REN, Peiyang ZHOU. S1PR5 activation or overexpression enhances barrier function of mouse brain microvascular endothelial cells against OGD/R injury by modulating oxidative stress [J]. Journal of Southern Medical University, 2025, 45(7): 1451-1459.
[6]	Tingting YANG, Li ZHAO. A stable mouse model of chronic liver fibrosis induced by vitamin A deficiency and intraperitoneal CCl₄ injection [J]. Journal of Southern Medical University, 2025, 45(7): 1527-1534.
[7]	Lijun HE, Xiaofei CHEN, Chenxin YAN, Lin SHI. Inhibitory effect of Fuzheng Huaji Decoction against non-small cell lung cancer cells in vitro and the possible molecular mechanism [J]. Journal of Southern Medical University, 2025, 45(6): 1143-1152.
[8]	Xinheng WANG, Xiaohan SHAO, Tongtong LI, Lu ZHANG, Qinjun YANG, Weidong YE, Jiabing TONG, Zegeng LI, Xiangming FANG. Pingchuanning Formula suppresses airway inflammation in a rat model of asthmatic cold syndrome by regulating the HMGB1/Beclin-1 axis-mediated autophagy [J]. Journal of Southern Medical University, 2025, 45(6): 1153-1162.
[9]	Guoyong LI, Renling LI, Yiting LIU, Hongxia KE, Jing LI, Xinhua WANG. Therapeutic mechanism of Arctium lappa extract for post-viral pneumonia pulmonary fibrosis: a metabolomics, network pharmacology analysis and experimental verification [J]. Journal of Southern Medical University, 2025, 45(6): 1185-1199.
[10]	Liping GUAN, Yan YAN, Xinyi LU, Zhifeng LI, Hui GAO, Dong CAO, Chenxi HOU, Jingyu ZENG, Xinyi LI, Yang ZHAO, Junjie WANG, Huilong FANG. Compound Centella asiatica formula alleviates Schistosoma japonicum-induced liver fibrosis in mice by inhibiting the inflammation-fibrosis cascade via regulating the TLR4/MyD88 pathway [J]. Journal of Southern Medical University, 2025, 45(6): 1307-1316.
[11]	Yumeng YE, Bo YU, Shasha LU, Yu ZHOU, Meihong DING, Guilin CHENG. Design and inflammation-targeting efficiency assessment of an engineered liposome-based nanomedicine delivery system targeting E-selectin [J]. Journal of Southern Medical University, 2025, 45(5): 1013-1022.
[12]	Anbang ZHANG, Xiuqi SUN, Bo PANG, Yuanhua WU, Jingyu SHI, Ning ZHANG, Tao YE. Electroacupuncture pretreatment alleviates cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through the gut-brain axis and the Nrf2/HO-1 signaling pathway [J]. Journal of Southern Medical University, 2025, 45(5): 911-920.
[13]	Peipei TANG, Yong TAN, Yanyun YIN, Xiaowei NIE, Jingyu HUANG, Wenting ZUO, Yuling LI. Tiaozhou Ziyin recipe for treatment of premature ovarian insufficiency: efficacy, safety and mechanism [J]. Journal of Southern Medical University, 2025, 45(5): 929-941.
[14]	Xiaotao LIANG, Yifan XIONG, Xueqi LIU, Xiaoshan LIANG, Xiaoyu ZHU, Wei XIE. Huoxue Shufeng Granule alleviates central sensitization in chronic migraine mice via TLR4/NF-κB inflammatory pathway [J]. Journal of Southern Medical University, 2025, 45(5): 986-994.
[15]	Jiawen YU, Yi ZHOU, Chunmei QIAN, Lan MU, Renye QUE. Effects of liver fibrosis induced by iron overload on M2 polarization of macrophages in mice [J]. Journal of Southern Medical University, 2025, 45(4): 684-691.